(Q36134864)

12 August 2017

A prognostic index for multiple myeloma (English)

1 reference

12 August 2017

Grignani G

1

1 reference

12 August 2017

Gobbi PG

2

1 reference

12 August 2017

Formisano R

3

1 reference

12 August 2017

Pieresca C

4

1 reference

12 August 2017

Ucci G

5

1 reference

12 August 2017

Brugnatelli S

6

1 reference

12 August 2017

Riccardi A

7

1 reference

12 August 2017

Ascari E

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

73

1 reference

12 August 2017

1101-1107

1 reference

12 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1996.212

12 August 2017

0 references

cites work

The treatment of multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Newer approaches to the management of multiple myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Markers of multiple hematopoietic-cell lineages in multiple myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

A plea to overcome the concept of "staging" and related inadequacy in multiple myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Changing clinical presentation of multiple myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

In vitro growth of human multiple myeloma: implications for biology and therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Advances in the diagnosis and management of myeloma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Double-intensive therapy in high-risk multiple myeloma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Classification of patients affected by multiple myeloma using a neural network software.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

The treatment of multiple myeloma--an important MRC trial

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

A new improved clinical staging system for multiple myeloma based on analysis of 123 treated patients.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Treatment of multiple myeloma: a randomized study of three different regimens

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Peptichemio, vincristine and prednisone versus melphalan and prednisone as induction therapy in multiple myeloma.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Prognostic significance of plasma cell morphology in multiple myeloma

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Limited value of myeloablative therapy for late multiple myeloma.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Prognostic relevance of cellular morphology in multiple myeloma.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074407

Development of a criterion for response to therapy at 6 months in multiple myeloma

23 September 2018

1 reference

12 December 2020

The growth fraction of human myeloma cells

1 reference

12 December 2020

Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging

1 reference

12 December 2020

Multiple myeloma: significance of plasmablastic subtype in morphological classification

1 reference

12 December 2020

Pre-B cells in peripheral blood of multiple myeloma patients

1 reference

12 December 2020

Consolidation and maintenance therapy in multiple myeloma: randomized comparison of a new approach to therapy after initial response to treatment

1 reference

12 December 2020

Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB Study

1 reference

12 December 2020

Plasmablastic multiple myeloma: an immunologically different subtype

1 reference

12 December 2020

An update of two randomized trials in previously untreated multiple myeloma comparing melphalan and prednisone versus three- and five-drug combinations: an Argentine Group for the Treatment of Acute Leukemia Study

1 reference

12 December 2020

Histologic classification and staging of multiple myeloma

1 reference

12 December 2020

Results of the MRC myelomatosis trials for patients entered since 1980

1 reference

12 December 2020

Prognostic significance of plasma cell morphology in multiple myeloma

1 reference

12 December 2020

Intensive treatment of multiple myeloma and criteria for complete remission

1 reference

12 December 2020

Multiple myeloma: relationship between survival and cellular morphology

1 reference

12 December 2020

Intensive combined therapy for previously untreated aggressive myeloma

1 reference

12 December 2020

Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors

1 reference

12 December 2020

C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system

1 reference

12 December 2020

Utility of the examination of plasma-cell morphology in the study of multiple myeloma

1 reference

12 December 2020

Biology and treatment of multiple myeloma

1 reference

12 December 2020

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma

1 reference

12 December 2020

Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation

1 reference

12 December 2020

High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.212

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

1 reference